Shuxuetong injection and its peptides enhance angiogenesis after hindlimb ischemia by activating the MYPT1/LIMK1/Cofilin pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Shuxuetong injection and its peptides enhance angiogenesis after hindlimb ischemia by activating the MYPT1/LIMK1/Cofilin pathway

Published:2022-06 Issue: Volume:292 Page:115166
ISSN:0378-8741
Container-title:Journal of Ethnopharmacology
language:en
Short-container-title:Journal of Ethnopharmacology

Author:

Sun Wei,Zhang Lusha,Fang Zhirui,Han Lifeng,Wang Qianyi,Leng Yuze,Li Mengyao,Xue Yuejin,Wu Yongsheng,Li Zhenguo,Wang Hong,Chen Lu

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference41 articles.

1. A novel strategy to enhance angiogenesis in vivo using the small VEGF-binding peptide PR1P;Adini;Angiogenesis,2017

2. New directions in therapeutic angiogenesis and arteriogenesis in peripheral arterial disease;Annex;Circ. Res.,2021

3. LIM kinase 1 increases tumor metastasis of human breast cancer cells via regulation of the urokinase-type plasminogen activator system;Bagheri-Yarmand;Int. J. Cancer,2010

4. Sequential delivery of VEGF, FGF-2 and PDGF from the polymeric system enhance HUVECs angiogenesis in vitro and CAM angiogenesis;Bai;Cell. Immunol.,2017

5. Effects of traditional Chinese medicine Shuxuetong injection on random skin flap survival in rats;Cai;Sci. World J.,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Potentials of Medicinal Leech in Chinese Medicine;The American Journal of Chinese Medicine;2024-01

2. Chinese herbal injection for cardio-cerebrovascular disease: Overview and challenges;Frontiers in Pharmacology;2023-02-24

3. Identification and Quantification of Characteristic Peptides (Oligopeptides) in Shuxuetong (SXT) Injection by LC–MS/MS;Chromatographia;2022-10-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3